Related Experiment Video
Updated: Jun 4, 2025

Synthesis of an Intein-mediated Artificial Protein Hydrogel
Published on: January 27, 2014
Deep Learning-Driven Optimization of Antihypertensive Properties from Whey Protein Hydrolysates: A Multienzyme
Shuai Jiang1, Fan Mo1, Wenhan Li2
1College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China.
Deep learning identified an optimal enzyme combination for antihypertensive peptides from whey protein. This new method significantly reduced blood pressure and inflammation in hypertensive rats.
Area of Science:
- Biotechnology
- Nutritional Science
- Computational Biology
Background:
- Hypertension is a global health concern.
- Dietary peptides offer a promising avenue for blood pressure management.
- Optimizing peptide production requires advanced methodologies.
Purpose of the Study:
- To leverage deep learning and Large Language Models (LLMs) for optimizing antihypertensive peptides from whey protein hydrolysate.
- To evaluate the efficacy and stability of the optimized peptide combination.
- To investigate the underlying mechanisms of action in a hypertensive rat model.
Main Methods:
- Utilized Large Language Models (LLMs) to determine an optimal multienzyme combination (MC5).
- Assessed Angiotensin-Converting Enzyme (ACE) inhibition rate and biological stability through simulated digestion.
- Conducted in vivo studies on hypertensive rats, measuring blood pressure, inflammatory markers, antioxidant enzymes, and key vasoactive substances.
- Performed molecular docking to identify specific high-affinity binding peptides.
Main Results:
- MC5 achieved an 89.08% ACE inhibition rate, significantly outperforming single-enzyme hydrolysis.
- MC5 demonstrated excellent biological stability, with only a 6.87% decrease in ACE inhibition post-digestion.
- In vivo studies showed MC5 reduced systolic and diastolic blood pressure to 125.00 and 89.00 mmHg, respectively.
- MC5 modulated inflammatory markers, enhanced antioxidant enzyme activity, and favorably altered renin-angiotensin-aldosterone system (RAAS) components and nitric oxide (NO) levels.
- Identified four potent antihypertensive peptides (LPEW, LKPTPEGDL, LNYW, LLL) via molecular docking.
Conclusions:
- Deep learning and LLMs are effective tools for optimizing enzyme combinations in peptide hydrolysis for antihypertensive applications.
- The optimized whey protein hydrolysate (MC5) shows significant potential as a dietary intervention for hypertension.
- This integrated approach combining computational methods and enzymatic hydrolysis offers a novel strategy for developing functional foods and nutraceuticals.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics

